|
FOR IMMEDIATE RELEASE DEC
21, 2007
Contact: Glen Gordon MD 360-297-6858
NASA’s Space Alliance Technology Outreach Program (Satop)
Accepts EM-PROBE Technology Project
NASA’s SATOP program is a
free service designed to provide technical assistance and speed the transfer of space technology to private sector small businesses. EM-PROBE Technologies, a Puget Sound medical device company recently had its project proposal accepted by SATOP program directors. By providing
free technology assistance, SATOP helps small businesses solve their challenges and increase their chances of success in the marketplace.
EM-PROBE Technologies (EPT) markets the fastest pulse in the world approved to relieve pain after injury or illness. Reported to be as effective as moderate doses of morphine, the technology is free of side effects, non-invasive, and highly effective in treating local inflammation and trauma.
Research indicates the technology is also more widely bio-effective in healing tissues after major trauma, surgery, and conditions such as heart attack and stroke. EPT proposed its R & D challenge, a whole body system to protect persons suffering life-threatening challenges from surgery, heart attack, or stroke to NASA’s SATOP program directors, and the proposal was accepted.
Dr. Glen Gordon, founder of EPT noted, “I am honored by the acceptance of our R&D challenge, and the rapid manner in which SATOP NM Senior Program Engineer Manuel Durán connected us with Alliance partners possessing expertise specific to our opportunity”. Says Durán “through our vast expertise resource pool we were able to team EM-PROBE Technologies with Wyle Labs, one of our SATOP TX partners, that has expertise in the biomedical area”. Dr. Gordon sees this assistance elevating his company from a start-up position to that of a market disruptive potential.
SATOP can be reached at www.spacetechsolutions.com
About EM-PROBE Technologies
Sports medicine specialist and researcher, Dr. Glen Gordon founded EM-PROBE Technologies in 2001. Dr. Gordon, the first MD in the United States approved to treat humans with soft tissue injury and arthritis using nanosecond pulsed electromagnetic field technology, chaired the first symposium on free radical damage in sports injury presented at an annual meeting of The American College of Sports Medicine. An invited speaker at a 2006 W.H.O. international meeting on integrative medicine, he conducts research on his company's miniaturized, FDA-approved, hand held device, the result of 25 years of research and development. The company also provides information on PEMF technology and clinical studies through its Web site. For more information about EM-PROBE Technologies, please visit www.em-probe.com, or call 1-888-697-9996.
|
